Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 334 of 334 entries
Sorted by: Best Match Show Resources per page
Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection.

BMC microbiology

Nasrin S, Hegerle N, Sen S, Nkeze J, Sen S, Permala-Booth J, Choi M, Sinclair J, Tapia MD, Johnson JK, Sow SO, Thaden JT, Fowler VG, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM.
PMID: 34991476
BMC Microbiol. 2022 Jan 06;22(1):13. doi: 10.1186/s12866-021-02427-4.

BACKGROUND: Pseudomonas aeruginosa is an opportunistic pathogen that causes a wide range of acute and chronic infections and is frequently associated with healthcare-associated infections. Because of its ability to rapidly acquire resistance to antibiotics, P. aeruginosa infections are difficult...

Cite
Nasrin S, Hegerle N, Sen S, et al. Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol. 2022;22(1):13doi: 10.1186/s12866-021-02427-4.
Nasrin, S., Hegerle, N., Sen, S., Nkeze, J., Sen, S., Permala-Booth, J., Choi, M., Sinclair, J., Tapia, M. D., Johnson, J. K., Sow, S. O., Thaden, J. T., Fowler, V. G., Krogfelt, K. A., Brauner, A., Protonotariou, E., Christaki, E., Shindo, Y., Kwa, A. L., Shakoor, S., Singh-Moodley, A., Perovic, O., Jacobs, J., Lunguya, O., Simon, R., Cross, A. S., & Tennant, S. M. (2022). Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC microbiology, 22(1), 13. https://doi.org/10.1186/s12866-021-02427-4
Nasrin, Shamima, et al. "Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection." BMC microbiology vol. 22,1 (2022): 13. doi: https://doi.org/10.1186/s12866-021-02427-4
Nasrin S, Hegerle N, Sen S, Nkeze J, Sen S, Permala-Booth J, Choi M, Sinclair J, Tapia MD, Johnson JK, Sow SO, Thaden JT, Fowler VG, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM. Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol. 2022 Jan 06;22(1):13. doi: 10.1186/s12866-021-02427-4. PMID: 34991476; PMCID: PMC8732956.
Copy Download .nbib Format: NLM
Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records.

The lancet. Diabetes & endocrinology

Pearson-Stuttard J, Cheng YJ, Bennett J, Vamos EP, Zhou B, Valabhji J, Cross AJ, Ezzati M, Gregg EW.
PMID: 34861153
Lancet Diabetes Endocrinol. 2022 Jan;10(1):46-57. doi: 10.1016/S2213-8587(21)00288-6. Epub 2021 Nov 30.

BACKGROUND: Diabetes leads to a wide range of established vascular and metabolic complications that has resulted in the implementation of diverse prevention programmes across high-income countries. Diabetes has also been associated with an increased risk of a broader set...

Cite
Pearson-Stuttard J, Cheng YJ, Bennett J, et al. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2021;10(1):46-57doi: 10.1016/S2213-8587(21)00288-6.
Pearson-Stuttard, J., Cheng, Y. J., Bennett, J., Vamos, E. P., Zhou, B., Valabhji, J., Cross, A. J., Ezzati, M., & Gregg, E. W. (2022). Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. The lancet. Diabetes & endocrinology, 10(1), 46-57. https://doi.org/10.1016/S2213-8587(21)00288-6
Pearson-Stuttard, Jonathan, et al. "Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records." The lancet. Diabetes & endocrinology vol. 10,1 (2022): 46-57. doi: https://doi.org/10.1016/S2213-8587(21)00288-6
Pearson-Stuttard J, Cheng YJ, Bennett J, Vamos EP, Zhou B, Valabhji J, Cross AJ, Ezzati M, Gregg EW. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2022 Jan;10(1):46-57. doi: 10.1016/S2213-8587(21)00288-6. Epub 2021 Nov 30. PMID: 34861153.
Copy Download .nbib Format: NLM
Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records.

The lancet. Diabetes & endocrinology

Pearson-Stuttard J, Cheng YJ, Bennett J, Vamos EP, Zhou B, Valabhji J, Cross AJ, Ezzati M, Gregg EW.
PMID: 34861153
Lancet Diabetes Endocrinol. 2022 Jan;10(1):46-57. doi: 10.1016/S2213-8587(21)00288-6. Epub 2021 Nov 30.

BACKGROUND: Diabetes leads to a wide range of established vascular and metabolic complications that has resulted in the implementation of diverse prevention programmes across high-income countries. Diabetes has also been associated with an increased risk of a broader set...

Cite
Pearson-Stuttard J, Cheng YJ, Bennett J, et al. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2021;10(1):46-57doi: 10.1016/S2213-8587(21)00288-6.
Pearson-Stuttard, J., Cheng, Y. J., Bennett, J., Vamos, E. P., Zhou, B., Valabhji, J., Cross, A. J., Ezzati, M., & Gregg, E. W. (2022). Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. The lancet. Diabetes & endocrinology, 10(1), 46-57. https://doi.org/10.1016/S2213-8587(21)00288-6
Pearson-Stuttard, Jonathan, et al. "Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records." The lancet. Diabetes & endocrinology vol. 10,1 (2022): 46-57. doi: https://doi.org/10.1016/S2213-8587(21)00288-6
Pearson-Stuttard J, Cheng YJ, Bennett J, Vamos EP, Zhou B, Valabhji J, Cross AJ, Ezzati M, Gregg EW. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2022 Jan;10(1):46-57. doi: 10.1016/S2213-8587(21)00288-6. Epub 2021 Nov 30. PMID: 34861153.
Copy Download .nbib Format: NLM
The Aerogen.

Pharmaceutics

Dallas RH, Rains JK, Wilder K, Humphrey W, Cross SJ, Ghafoor S, Brazelton de Cardenas JN, Hayden RT, Hijano DR.
PMID: 33260359
Pharmaceutics. 2020 Nov 29;12(12). doi: 10.3390/pharmaceutics12121163.

Respiratory syncytial virus (RSV) is associated with adverse outcomes among immunocompromised patients. Inhaled ribavirin has been shown to improve mortality rates. The Small-Particle Aerosol Generator delivery system (SPAG-2) is the only FDA-cleared device to deliver inhaled ribavirin. However, it...

Cite
Dallas RH, Rains JK, Wilder K, et al. The Aerogen. Pharmaceutics. 2020;12(12)doi: 10.3390/pharmaceutics12121163.
Dallas, R. H., Rains, J. K., Wilder, K., Humphrey, W., Cross, S. J., Ghafoor, S., Brazelton de Cardenas, J. N., Hayden, R. T., & Hijano, D. R. (2020). The Aerogen. Pharmaceutics, 12(12), . https://doi.org/10.3390/pharmaceutics12121163
Dallas, Ronald H, et al. "The Aerogen." Pharmaceutics vol. 12,12 (2020). doi: https://doi.org/10.3390/pharmaceutics12121163
Dallas RH, Rains JK, Wilder K, Humphrey W, Cross SJ, Ghafoor S, Brazelton de Cardenas JN, Hayden RT, Hijano DR. The Aerogen. Pharmaceutics. 2020 Nov 29;12(12). doi: 10.3390/pharmaceutics12121163. PMID: 33260359; PMCID: PMC7760766.
Copy Download .nbib Format: NLM
A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.

The Journal of biological chemistry

Tang XH, Melis M, Lu C, Rappa A, Zhang T, Jessurun J, Gross SS, Gudas LJ.
PMID: 34688661
J Biol Chem. 2021 Oct 21;297(6):101331. doi: 10.1016/j.jbc.2021.101331. Epub 2021 Oct 21.

Nonalcohol-associated fatty liver disease (NAFLD) is characterized by excessive hepatic accumulation of fat that can progress to steatohepatitis, and currently, therapeutic options are limited. Using a high-fat diet (HFD) mouse model of NAFLD, we determined the effects of the...

Cite
Tang XH, Melis M, Lu C, et al. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. J Biol Chem. 2021;297(6):101331doi: 10.1016/j.jbc.2021.101331.
Tang, X. H., Melis, M., Lu, C., Rappa, A., Zhang, T., Jessurun, J., Gross, S. S., & Gudas, L. J. (2021). A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. The Journal of biological chemistry, 297(6), 101331. https://doi.org/10.1016/j.jbc.2021.101331
Tang, Xiao-Han, et al. "A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease." The Journal of biological chemistry vol. 297,6 (2021): 101331. doi: https://doi.org/10.1016/j.jbc.2021.101331
Tang XH, Melis M, Lu C, Rappa A, Zhang T, Jessurun J, Gross SS, Gudas LJ. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. J Biol Chem. 2021 Oct 21;297(6):101331. doi: 10.1016/j.jbc.2021.101331. Epub 2021 Oct 21. PMID: 34688661; PMCID: PMC8626588.
Copy Download .nbib Format: NLM
Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women.

Open forum infectious diseases

Summers NA, Huynh TT, Dunn RC, Cross SL, Fuchs CJ.
PMID: 34514019
Open Forum Infect Dis. 2021 Jul 30;8(9):ofab404. doi: 10.1093/ofid/ofab404. eCollection 2021 Sep.

BACKGROUND: Progression along the HIV care continuum has been a key focus for improving outcomes for people with HIV (PWH). Transgender women with HIV (TGWWH) have not made the same progress as their cisgender counterparts.METHODS: All PWH identifying as...

Cite
Summers NA, Huynh TT, Dunn RC, et al. Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women. Open Forum Infect Dis. 2021;8(9):ofab404doi: 10.1093/ofid/ofab404.
Summers, N. A., Huynh, T. T., Dunn, R. C., Cross, S. L., & Fuchs, C. J. (2021). Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women. Open forum infectious diseases, 8(9), ofab404. https://doi.org/10.1093/ofid/ofab404
Summers, Nathan A, et al. "Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women." Open forum infectious diseases vol. 8,9 (2021): ofab404. doi: https://doi.org/10.1093/ofid/ofab404
Summers NA, Huynh TT, Dunn RC, Cross SL, Fuchs CJ. Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women. Open Forum Infect Dis. 2021 Jul 30;8(9):ofab404. doi: 10.1093/ofid/ofab404. eCollection 2021 Sep. PMID: 34514019; PMCID: PMC8415531.
Copy Download .nbib Format: NLM
Patients With Preoperative Clinical Depression Symptomology Experience Significant Improvements in Postoperative Pain, Function, and Depressive Symptoms Following Rotator Cuff Repair.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association

Hessburg LT, Ziedas AC, Cross AG, Elhage K, Guo EW, Yedulla N, Koolmees D, Muh SJ, Moutzouros V, Makhni EC.
PMID: 34052382
Arthroscopy. 2021 Dec;37(12):3408-3413. doi: 10.1016/j.arthro.2021.05.020. Epub 2021 May 27.

PURPOSE: To determine the impact of clinical depression on outcomes after rotator cuff repair (RCR), as measured by Patient-Reported Outcomes Measurement Information System (PROMIS) Computer Adaptive Test (CAT) health domains.METHODS: RCR patients were given PROMIS CAT assessments for physical...

Cite
Hessburg LT, Ziedas AC, Cross AG, et al. Patients With Preoperative Clinical Depression Symptomology Experience Significant Improvements in Postoperative Pain, Function, and Depressive Symptoms Following Rotator Cuff Repair. Arthroscopy. 2021;37(12):3408-3413doi: 10.1016/j.arthro.2021.05.020.
Hessburg, L. T., Ziedas, A. C., Cross, A. G., Elhage, K., Guo, E. W., Yedulla, N., Koolmees, D., Muh, S. J., Moutzouros, V., & Makhni, E. C. (2021). Patients With Preoperative Clinical Depression Symptomology Experience Significant Improvements in Postoperative Pain, Function, and Depressive Symptoms Following Rotator Cuff Repair. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 37(12), 3408-3413. https://doi.org/10.1016/j.arthro.2021.05.020
Hessburg, Luke T, et al. "Patients With Preoperative Clinical Depression Symptomology Experience Significant Improvements in Postoperative Pain, Function, and Depressive Symptoms Following Rotator Cuff Repair." Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association vol. 37,12 (2021): 3408-3413. doi: https://doi.org/10.1016/j.arthro.2021.05.020
Hessburg LT, Ziedas AC, Cross AG, Elhage K, Guo EW, Yedulla N, Koolmees D, Muh SJ, Moutzouros V, Makhni EC. Patients With Preoperative Clinical Depression Symptomology Experience Significant Improvements in Postoperative Pain, Function, and Depressive Symptoms Following Rotator Cuff Repair. Arthroscopy. 2021 Dec;37(12):3408-3413. doi: 10.1016/j.arthro.2021.05.020. Epub 2021 May 27. PMID: 34052382.
Copy Download .nbib Format: NLM
The Presence of Preoperative Depression Symptoms Does Not Hinder Recovery After Anterior Cruciate Ligament Reconstruction.

Orthopaedic journal of sports medicine

Guo EW, Cross AG, Hessburg L, Koolmees D, Bernstein DN, Elhage KG, Moutzouros V, Makhni EC.
PMID: 33786331
Orthop J Sports Med. 2021 Jan 20;9(1):2325967120970219. doi: 10.1177/2325967120970219. eCollection 2021 Jan.

BACKGROUND: The current literature suggests a link between psychosocial factors and poor surgical outcomes in patients with musculoskeletal complaints. However, there remains a limited body of literature examining the effect of depression on outcomes after anterior cruciate ligament reconstruction...

Cite
Guo EW, Cross AG, Hessburg L, et al. The Presence of Preoperative Depression Symptoms Does Not Hinder Recovery After Anterior Cruciate Ligament Reconstruction. Orthop J Sports Med. 2021;9(1):2325967120970219doi: 10.1177/2325967120970219.
Guo, E. W., Cross, A. G., Hessburg, L., Koolmees, D., Bernstein, D. N., Elhage, K. G., Moutzouros, V., & Makhni, E. C. (2021). The Presence of Preoperative Depression Symptoms Does Not Hinder Recovery After Anterior Cruciate Ligament Reconstruction. Orthopaedic journal of sports medicine, 9(1), 2325967120970219. https://doi.org/10.1177/2325967120970219
Guo, Eric W, et al. "The Presence of Preoperative Depression Symptoms Does Not Hinder Recovery After Anterior Cruciate Ligament Reconstruction." Orthopaedic journal of sports medicine vol. 9,1 (2021): 2325967120970219. doi: https://doi.org/10.1177/2325967120970219
Guo EW, Cross AG, Hessburg L, Koolmees D, Bernstein DN, Elhage KG, Moutzouros V, Makhni EC. The Presence of Preoperative Depression Symptoms Does Not Hinder Recovery After Anterior Cruciate Ligament Reconstruction. Orthop J Sports Med. 2021 Jan 20;9(1):2325967120970219. doi: 10.1177/2325967120970219. eCollection 2021 Jan. PMID: 33786331; PMCID: PMC7960906.
Copy Download .nbib Format: NLM
Alterations of the gut mycobiome in patients with MS.

EBioMedicine

Shah S, Locca A, Dorsett Y, Cantoni C, Ghezzi L, Lin Q, Bokoliya S, Panier H, Suther C, Gormley M, Liu Y, Evans E, Mikesell R, Obert K, Salter A, Cross AH, Tarr PI, Lovett-Racke A, Piccio L, Zhou Y.
PMID: 34455391
EBioMedicine. 2021 Sep;71:103557. doi: 10.1016/j.ebiom.2021.103557. Epub 2021 Aug 26.

BACKGROUND: The mycobiome is the fungal component of the gut microbiome and is implicated in several autoimmune diseases. However, its role in MS has not been studied.METHODS: In this case-control observational study, we performed ITS sequencing and characterised the...

Cite
Shah S, Locca A, Dorsett Y, et al. Alterations of the gut mycobiome in patients with MS. EBioMedicine. 2021;71:103557doi: 10.1016/j.ebiom.2021.103557.
Shah, S., Locca, A., Dorsett, Y., Cantoni, C., Ghezzi, L., Lin, Q., Bokoliya, S., Panier, H., Suther, C., Gormley, M., Liu, Y., Evans, E., Mikesell, R., Obert, K., Salter, A., Cross, A. H., Tarr, P. I., Lovett-Racke, A., Piccio, L., & Zhou, Y. (2021). Alterations of the gut mycobiome in patients with MS. EBioMedicine, 71103557. https://doi.org/10.1016/j.ebiom.2021.103557
Shah, Saumya, et al. "Alterations of the gut mycobiome in patients with MS." EBioMedicine vol. 71 (2021): 103557. doi: https://doi.org/10.1016/j.ebiom.2021.103557
Shah S, Locca A, Dorsett Y, Cantoni C, Ghezzi L, Lin Q, Bokoliya S, Panier H, Suther C, Gormley M, Liu Y, Evans E, Mikesell R, Obert K, Salter A, Cross AH, Tarr PI, Lovett-Racke A, Piccio L, Zhou Y. Alterations of the gut mycobiome in patients with MS. EBioMedicine. 2021 Sep;71:103557. doi: 10.1016/j.ebiom.2021.103557. Epub 2021 Aug 26. PMID: 34455391; PMCID: PMC8399064.
Copy Download .nbib Format: NLM
Wnt16 Elicits a Protective Effect Against Fractures and Supports Bone Repair in Zebrafish.

JBMR plus

McGowan LM, Kague E, Vorster A, Newham E, Cross S, Hammond CL.
PMID: 33778326
JBMR Plus. 2021 Feb 02;5(3):e10461. doi: 10.1002/jbm4.10461. eCollection 2021 Mar.

Bone homeostasis is a dynamic, multicellular process that is required throughout life to maintain bone integrity, prevent fracture, and respond to skeletal damage.

Cite
McGowan LM, Kague E, Vorster A, et al. Wnt16 Elicits a Protective Effect Against Fractures and Supports Bone Repair in Zebrafish. JBMR Plus. 2021;5(3):e10461doi: 10.1002/jbm4.10461.
McGowan, L. M., Kague, E., Vorster, A., Newham, E., Cross, S., & Hammond, C. L. (2021). Wnt16 Elicits a Protective Effect Against Fractures and Supports Bone Repair in Zebrafish. JBMR plus, 5(3), e10461. https://doi.org/10.1002/jbm4.10461
McGowan, Lucy M, et al. "Wnt16 Elicits a Protective Effect Against Fractures and Supports Bone Repair in Zebrafish." JBMR plus vol. 5,3 (2021): e10461. doi: https://doi.org/10.1002/jbm4.10461
McGowan LM, Kague E, Vorster A, Newham E, Cross S, Hammond CL. Wnt16 Elicits a Protective Effect Against Fractures and Supports Bone Repair in Zebrafish. JBMR Plus. 2021 Feb 02;5(3):e10461. doi: 10.1002/jbm4.10461. eCollection 2021 Mar. PMID: 33778326; PMCID: PMC7990157.
Copy Download .nbib Format: NLM
Showing 325 to 334 of 334 entries